PLX · Company research
Protalix BioTherapeutics, Inc. Common Stock (PLX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A Hungarian fund manager reports a stake above 5% in Protalix BioTherapeutics (PLX). - Stock Titan | A Hungarian fund manager reports a stake above 5% in Protalix BioTherapeutics (PLX). Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| XOFPLX=X interactive stock chart | XOF/PLX stock - Yahoo Finance Australia | XOFPLX=X interactive stock chart | XOF/PLX stock Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 9, 2026 | neutral | 0 | 0.6 |
| XOFPLX=X Interactive Stock Chart | XOF/PLX Stock - Yahoo Finance | XOFPLX=X Interactive Stock Chart | XOF/PLX Stock Yahoo Finance | View source ↗ | Yahoo Finance | Oct 6, 2026 | neutral | 0 | 0.6 |
| (AMEX: PLX) Share Price, PLX Stock News, PLX Share Price & Updates - kalkine.ca | (AMEX: PLX) Share Price, PLX Stock News, PLX Share Price & Updates kalkine.ca | View source ↗ | kalkine.ca | Sep 17, 2026 | neutral | 0 | 0.6 |
| Director at Protalix (NYSE: PLX) gets options expiring 2036 plus 8,500 RSUs - Stock Titan | Director at Protalix (NYSE: PLX) gets options expiring 2036 plus 8,500 RSUs Stock Titan | View source ↗ | Stock Titan | Sep 9, 2026 | neutral | 0 | 0.6 |
| Director at Protalix BioTherapeutics (PLX) gets new options and stock units - Stock Titan | Director at Protalix BioTherapeutics (PLX) gets new options and stock units Stock Titan | View source ↗ | Stock Titan | Sep 4, 2026 | neutral | 0 | 0.6 |
| PLX Stock Price, Quote & News - Syfe | PLX Stock Price, Quote & News Syfe | View source ↗ | Syfe | Aug 29, 2026 | neutral | 0 | 0.6 |
| Protalix (PLX) Stock Profit Swing Sharpens Focus On Elfabrio Reliance - Simply Wall Street | Protalix (PLX) Stock Profit Swing Sharpens Focus On Elfabrio Reliance Simply Wall Street | View source ↗ | Simply Wall Street | Aug 13, 2026 | neutral | 0 | 0.6 |
| Protalix BioTherapeutics (PLX) Slips 1% as Shares Hover Between Support and Resistance - Flat Correction - www.dars.gov.et | Protalix BioTherapeutics (PLX) Slips 1% as Shares Hover Between Support and Resistance - Flat Correction www.dars.gov.et | View source ↗ | www.dars.gov.et | Aug 10, 2026 | neutral | 0 | 0.6 |
| PLX Forecast — Price Target — Prediction for 2027 - TradingView | PLX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Protalix Revenue Miss Overshadowed By Milestone-Backed 2026 Guidance (NYSE:PLX) - Seeking Alpha | Protalix Revenue Miss Overshadowed By Milestone-Backed 2026 Guidance (NYSE:PLX) Seeking Alpha | View source ↗ | Seeking Alpha | Mar 24, 2026 | neutral | 0 | 0.6 |
| A Look At Protalix BioTherapeutics (PLX) Valuation After Elfabrio Dosing Approval And Updated 2026 Revenue Guidance - Simply Wall Street | A Look At Protalix BioTherapeutics (PLX) Valuation After Elfabrio Dosing Approval And Updated 2026 Revenue Guidance Simply Wall Street | View source ↗ | Simply Wall Street | Mar 20, 2026 | neutral | 0 | 0.6 |
| $PLX ($PLX) Releases Q4 2025 Earnings - Quiver Quantitative | $PLX ($PLX) Releases Q4 2025 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | Mar 18, 2026 | neutral | 0 | 0.6 |
| PLX Shares Jump 13% On EMA Committee’s Turnaround On New Dosing Regimen For Fabry Disease Therapy - Stocktwits | PLX Shares Jump 13% On EMA Committee’s Turnaround On New Dosing Regimen For Fabry Disease Therapy Stocktwits | View source ↗ | Stocktwits | Jan 30, 2026 | neutral | 0 | 0.6 |
| Protalix BioTherapeutics, Inc. Common Stock (PLX) Stock Price: Oct 8 Close $2.70 - Gotrade | Protalix BioTherapeutics, Inc. Common Stock (PLX) Stock Price: Oct 8 Close $2.70 Gotrade | View source ↗ | Gotrade | Jan 14, 2026 | neutral | 0 | 0.6 |
| Protalix BioTherapeutics Inc. (PLX) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits | Protalix BioTherapeutics Inc. (PLX) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength Stocktwits | View source ↗ | Stocktwits | Nov 9, 2022 | neutral | 0 | 0.6 |
| Protalix BioTherapeutics, Inc. (PLX) stock price, news, quote and history - Yahoo Finance Singapore | Protalix BioTherapeutics, Inc. (PLX) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | May 9, 2017 | neutral | 0 | 0.6 |
| Protalix BioTherapeutics, Inc. (PLX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Protalix BioTherapeutics, Inc. (PLX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | May 5, 2017 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.